Dean Capital Investments Management LLC Purchases Shares of 4,107 Walgreens Boots Alliance Inc (NASDAQ:WBA)

Dean Capital Investments Management LLC purchased a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 4,107 shares of the pharmacy operator’s stock, valued at approximately $298,000.

Several other institutional investors have also added to or reduced their stakes in WBA. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Walgreens Boots Alliance by 1.3% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 381,931 shares of the pharmacy operator’s stock worth $27,736,000 after purchasing an additional 4,718 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its stake in Walgreens Boots Alliance by 61.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 46,011 shares of the pharmacy operator’s stock valued at $3,342,000 after buying an additional 17,455 shares in the last quarter. Eads & Heald Investment Counsel boosted its stake in Walgreens Boots Alliance by 3.6% in the fourth quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after buying an additional 748 shares in the last quarter. Mutual of America Capital Management LLC boosted its stake in Walgreens Boots Alliance by 4.8% in the fourth quarter. Mutual of America Capital Management LLC now owns 182,196 shares of the pharmacy operator’s stock valued at $13,231,000 after buying an additional 8,361 shares in the last quarter. Finally, Dupont Capital Management Corp boosted its stake in Walgreens Boots Alliance by 16.9% in the fourth quarter. Dupont Capital Management Corp now owns 78,207 shares of the pharmacy operator’s stock valued at $5,679,000 after buying an additional 11,282 shares in the last quarter. 61.24% of the stock is owned by institutional investors and hedge funds.

Several analysts recently weighed in on the company. Needham & Company LLC reduced their price objective on Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a research note on Wednesday, November 22nd. Jefferies Group set a $93.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. Pivotal Research set a $73.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Friday, January 5th. Vetr upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Finally, Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd. Eleven equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $85.53.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) traded up $0.24 on Friday, hitting $68.46. The stock had a trading volume of 6,664,994 shares, compared to its average volume of 5,910,000. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $67,820.00, a P/E ratio of 18.91, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. During the same period last year, the company earned $1.10 earnings per share. The firm’s revenue was up 7.9% compared to the same quarter last year. research analysts predict that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a dividend of $0.40 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.34%. Walgreens Boots Alliance’s payout ratio is 44.20%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are typically an indication that the company’s leadership believes its shares are undervalued.

In related news, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction that occurred on Monday, January 15th. The shares were bought at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 14.80% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This article was first published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://ledgergazette.com/2018/02/11/dean-capital-investments-management-llc-takes-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply